These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 36270580)

  • 1. Effects of Mutations and Post-Translational Modifications on α-Synuclein In Vitro Aggregation.
    Pancoe SX; Wang YJ; Shimogawa M; Perez RM; Giannakoulias S; Petersson EJ
    J Mol Biol; 2022 Dec; 434(23):167859. PubMed ID: 36270580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Lipids on α-Synuclein Aggregation In Vitro.
    Ramirez J; Pancoe SX; Rhoades E; Petersson EJ
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity.
    Murata T; Tochio N; Utsunomiya-Tate N
    Neurosci Lett; 2021 Aug; 760():136077. PubMed ID: 34161822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils.
    Yang X; Wang B; Hoop CL; Williams JK; Baum J
    Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glimpse into the structural properties of α-synuclein oligomers.
    Santos J; Pallarès I; Ventura S
    Biofactors; 2024; 50(3):439-449. PubMed ID: 38063360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Parkinson disease mutations influence α-synuclein assembly.
    Ono K; Ikeda T; Takasaki J; Yamada M
    Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoenzymatic Semisynthesis of Phosphorylated α-Synuclein Enables Identification of a Bidirectional Effect on Fibril Formation.
    Pan B; Rhoades E; Petersson EJ
    ACS Chem Biol; 2020 Mar; 15(3):640-645. PubMed ID: 32065743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The A53E α-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture.
    Rutherford NJ; Giasson BI
    Neurosci Lett; 2015 Jun; 597():43-8. PubMed ID: 25892596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.
    Ghosh D; Mondal M; Mohite GM; Singh PK; Ranjan P; Anoop A; Ghosh S; Jha NN; Kumar A; Maji SK
    Biochemistry; 2013 Oct; 52(40):6925-7. PubMed ID: 24047453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico analysis of alpha-synuclein protein variants and posttranslational modifications related to Parkinson's disease.
    da Silva ANR; Pereira GRC; Bonet LFS; Outeiro TF; De Mesquita JF
    J Cell Biochem; 2024 Mar; 125(3):e30523. PubMed ID: 38239037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation.
    Bickle L; Hopwood JJ; Karageorgos L
    Biochim Biophys Acta Proteins Proteom; 2017 Mar; 1865(3):261-273. PubMed ID: 28007442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-synuclein-assisted oligomerization of β-amyloid (1-42).
    Chau E; Kim JR
    Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Glutamate Arginylation on α-Synuclein: Studying an Unusual Post-Translational Modification through Semisynthesis.
    Pan B; Kamo N; Shimogawa M; Huang Y; Kashina A; Rhoades E; Petersson EJ
    J Am Chem Soc; 2020 Dec; 142(52):21786-21798. PubMed ID: 33337869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease.
    de Oliveira GAP; Silva JL
    Commun Biol; 2019; 2():374. PubMed ID: 31633065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding.
    Meade RM; Watt KJC; Williams RJ; Mason JM
    J Mol Biol; 2021 Dec; 433(24):167323. PubMed ID: 34695381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of Cu
    Lorentzon E; Kumar R; Horvath I; Wittung-Stafshede P
    Biometals; 2020 Jun; 33(2-3):97-106. PubMed ID: 32170541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ellagic Acid Modulates Uninduced as well as Mutation and Metal-Induced Aggregation of α-Synuclein: Implications for Parkinson's Disease.
    Meena VK; Kumar V; Karalia S; Garima ; Sundd M
    ACS Chem Neurosci; 2021 Oct; 12(19):3598-3614. PubMed ID: 34506119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Pathogenic Mutations in α-Synuclein on Biophysical and Structural Characteristics of Amyloid Fibrils.
    Ruggeri FS; Flagmeier P; Kumita JR; Meisl G; Chirgadze DY; Bongiovanni MN; Knowles TPJ; Dobson CM
    ACS Nano; 2020 May; 14(5):5213-5222. PubMed ID: 32159944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation.
    Flagmeier P; Meisl G; Vendruscolo M; Knowles TP; Dobson CM; Buell AK; Galvagnion C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10328-33. PubMed ID: 27573854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.